Both medications activate GLP-1 receptors that influence hunger and food intake
Paul Conti, M.D., a psychiatrist who did his medical training at Stanford School of Medicine and residency at Harvard Medical School
S3-Leitlinie Komplementrmedizin in der Behandlung von onkologischen PatientInnen Langversion Mai 2024, AWMF-Registernummer: 032/055OL Sato S, Namisaki T, Furukawa M, Saikawa S, Kawaratani H, Kaji K, Takaya H, Shimozato N, Sawada Y, Kitagawa K, Moriya K, Akahane T, Mitoro A, Hoki N, Ann T, Yoshiji H
Anti-VEGF injections are first-line treatment for center-involving diabetic macular edema and are also an accepted option for proliferative diabetic retinopathy when reliable follow-up is possible
Until those results are available, cardiovascular benefit remains unconfirmed